Jiaqiong Wang, MD, PhD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Gastrointestinal neuroendocrine tumors
- Prostate cancer and conditions
- Thyroid cancer and conditions
My Specialties
- Nuclear medicine
- PET scan
- MRI
Get to Know Me
I’m a nuclear medicine physician in the Molecular Imaging and Therapy Service within the Department of Radiology at Memorial Sloan Kettering Cancer Center.
I’m an expert in molecular imaging and radiopharmaceutical therapy. Molecular imaging uses radioactive tracers to detect cancer and provide information about how tumors behave inside the body. Radiopharmaceutical therapy uses targeted radioactive drugs to deliver treatment directly to cancer cells while minimizing effects on healthy tissues.
I use a variety of advanced imaging technologies, including CT, MRI, SPECT/CT, PET/CT, and PET/MRI, to diagnose cancer, determine the extent of disease, guide personalized treatment decisions, and assess how well treatments are working. By combining information about both the structure and function of tumors, these imaging tools help us provide the most appropriate care for each patient.
I’m an active member of several national and international imaging societies, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Neuroradiology (ASNR).
My clinical and research work focuses on advancing molecular imaging and theranostics – an approach that combines diagnostic imaging and targeted therapy — to improve cancer detection, treatment selection, and response assessment. My research includes developing and testing new PET tracers for brain tumors. I am also looking at better imaging approaches for head and neck tumors, paragangliomas, and prostate cancer. I have authored numerous peer-reviewed publications and book chapters and have presented my research at national and international conferences.
I'm a radiologist, which is a doctor with special training in using imaging to diagnose and treat disease. Imaging includes X-rays, sonography, ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI).
I’m a nuclear medicine physician, a doctor with special training in using radioactive drugs to diagnose and treat disease.
- Assistant Attending Physician
Conditions I Treat
- Gastrointestinal neuroendocrine tumors
- Prostate cancer and conditions
- Thyroid cancer and conditions
My Specialties
- Nuclear medicine
- PET scan
- MRI
- CT scan
- Neuroradiology
Education
- PhD, Neuroscience, Virginia Commonwealth University
- MD, Tongji Medical College of Huazhong University of Science and Technology, China
Residencies
- Nuclear Medicine, University of Miami Health System, Jackson Memorial Hospital
Fellowships
- Neuroradiology, University of Miami Health System, Jackson Memorial Hospital
Board Certifications
- American Board of Nuclear Medicine
Awards and Honors
- Michael Goldberger Award, National Neurotrauma Society (2010)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, HMO
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
PPO
This is a dual payer plan, which means 2 health insurance companies share this plan. MSK providers are out-of-network with UnitedHealthcare.
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
PPO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
EPO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
EPO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
PPO, HMO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
State Government
This plan is in-network at our New York sites only.
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO (City Employee Health Plans Gold and Gold Care Only)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, EPO
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
State Government
This plan is in-network at our New York sites only.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
- Osborne D, Cutler CS, Chaple IF, Ribeiro Pereira PM, Peterson TE, Solingapuram Sai KK, Wang J, Scott PJH, Chen DL. Industry-Academic Collaboration in Nuclear Medicine: Proceedings from the 2024 CMIIT Industry Partners Circle. J Nucl Med. 2026 May 28:jnumed.126.272619. doi: 10.2967/jnumed.126.272619. Epub ahead of print. PMID: 42209122.
- Wang J, Kuker R. Brain and Spinal Leptomeningeal Metastases in Prostate Cancer Detected by PSMA PET and MRI Fusion. Clin Nucl Med. 2026 Apr 1;51(4):332-334. doi: 10.1097/RLU.0000000000006328. Epub 2026 Mar 2. PMID: 41771034; PMCID: PMC12947911.
- Wang J, Kuker RA, Yu JQM, Jain N, McKinney AM, Quencer RM. Characterization of Sinonasal Lesions on CT, MRI, and PET/CT. Clin Nucl Med. 2025 Nov 1;50(11):1024-1030. doi: 10.1097/RLU.0000000000006101. Epub 2025 Sep 3. PMID: 40902154; PMCID: PMC12502930.
- Wang J, Serafini A, Kuker R, Ayubcha C, Cohen G, Nadel H, McKinney A, Alavi A, Yu JQ. The State-of-the-Art PET Tracers in Glioblastoma and High-grade Gliomas and Implications for Theranostics. PET Clin. 2025 Jan;20(1):147-164. doi: 10.1016/j.cpet.2024.09.009. Epub 2024 Oct 30. PMID: 39482219.
- Wang J, Kuker R. Concomitant Pancreatitis and Pancreatic Neuroendocrine Tumor on MRI and 68 Ga-DOTATATE PET/CT. Clin Nucl Med. 2024 Sep 1;49(9):868-872. doi: 10.1097/RLU.0000000000005279. Epub 2024 May 14. PMID: 38758529.
Visit PubMed for a full listing of Dr. Wang’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.